ABCB1 and acute myeloid leukemia: Furthermore, competitive inhibitors of ABCB1 such as quinine or cyclosporine A have been shown to reverse the MDR phenotype [12], and combination thereof with chemotherapy in high-risk AML with high ABCB1 activity resulted in better overall survival [13,14], although this was not confirmed by other studies [15,16].